SCHEMBL20428403

SCHEMBL20428403

CCCCC(=O)Oc1cc(N(C)c2cc(=O)oc3ccccc23)ccc1OC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.42
MAPT P10636 2/20 0.42
HDAC1 Q13547 3/20 0.39
HDAC8 Q9BY41 3/20 0.39
HDAC6 Q9UBN7 3/20 0.39
HDAC3 O15379 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39
CYP3A4 P08684 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
FPR1 P21462 1/20 0.39
KDM4E B2RXH2 4/20 0.38
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
RECQL P46063 1/20 0.38
PTGS2 P35354 1/20 0.38
LMNA P02545 3/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20420746 0.97 FPR1 (0.42) TP53MAPTHDAC1HDAC8HDAC6
SCHEMBL20420765 0.96 FPR1 (0.43) TP53MAPTHDAC1HDAC8HDAC6
SCHEMBL20420809 0.96 FPR1 (0.43) TP53MAPTHDAC1HDAC8HDAC6
SCHEMBL20428408 0.96 FPR1 (0.43) TP53MAPTHDAC1HDAC8HDAC6
SCHEMBL20420755 0.95 KMT2A (0.41) TP53MAPTHDAC1HDAC8HDAC6
SCHEMBL20428368 0.93 HDAC1 (0.41) HDAC1HDAC8HDAC6HDAC3HDAC2
SCHEMBL20428373 0.91 HDAC1 (0.41) TP53MAPTHDAC1HDAC8HDAC6
SCHEMBL20428327 0.90 KDM4E (0.42) TP53MAPTCYP3A4KDM4EKMT2A
SCHEMBL20420802 0.90 HDAC1 (0.42) TP53MAPTHDAC1HDAC8HDAC6
SCHEMBL20428410 0.90 TSHR (0.40) TP53MAPTHDAC1HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10544134-B2 4-substituted coumarin derivatives and preparation methods and uses thereof GUIZHOU BAILING GROUP PHARMACEUTICAL CO., LTD. (CN) 2020-01-28 US disclosed
EP-3354648-A1 4-SUBSTITUED COUMARIN DERIVATIVE, AND PREPARATION METHOD AND USE THEREOF Guizhou Bailing Group Pharmaceutical Co., Ltd. (CN) 2018-08-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10544134-B2 4-substituted coumarin derivatives and preparation methods and uses thereof MAP4, TUBA3C, ABCC1 TP53 714/4885MAPT 218/4885HDAC1 540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.